Jianzhen Shen
机构：Fujian Medical University, Union Hospital, Union Hospital
发表论文 115 篇 · 总被引 916 次 · h-index 15
代表论文
- Tucidinostat plus R-CHOP in previously untreated diffuse large B-cell lymphoma with double expression of MYC and BCL2: An interim analysis from the phase III DEB study. (2024 · Journal of Clinical Oncology · 被引 17)
- CD26lowPD-1+ CD8 T cells are terminally exhausted and associated with leukemia progression in acute myeloid leukemia (2023 · Frontiers in Immunology · 被引 11)
- Targeted agents plus CHOP compared with CHOP as the first-line treatment for newly diagnosed patients with peripheral T-cell lymphoma (GUIDANCE-03): an open-label, multicentre phase 2 clinical trial (2024 · The Lancet Regional Health - Western Pacific · 被引 7)
- Comparison of zuberitamab plus CHOP versus rituximab plus CHOP for the treatment of drug-naïve patients diagnosed with CD20-positive diffuse large B-cell lymphoma: a phase 3 trial (2024 · Journal for ImmunoTherapy of Cancer · 被引 6)
- A multicenter, open-label, single-arm, phase Ib clinical trial of HH2853 treatment in patients with relapsed and/or refractory peripheral T-cell lymphoma (2025 · Journal of Hematology & Oncology · 被引 5)
- LATS1 Promotes B-ALL Tumorigenesis by Regulating YAP1 Phosphorylation and Subcellular Localization (2024 · Current Medical Science · 被引 5)